GSK plc (OTC Pink - Current Information:GLAXF)
| 16.75 Delayed Data As of May 30 |  -0.16 / -0.95%Today’s Change | 13.48 Today|||52-Week Range 28.42 | -4.20% Year-to-Date |
Latest GLAXF News | Press Releases
| Pfizer's (PFE) RSV Vaccine for Infants Gets FDA Panel Vote May 19 / Zacks.com - Paid Partner Content |
Today’s Trading
| Previous close | 16.91 |
| Today’s open | 16.69 |
| Day’s range | 16.69 - 16.75 |
| Volume | 14,012 |
| Average volume (3 months) | 2,424 |
| Market cap | $69.2B |
Data as of 05/30/2023
Growth & Valuation
| Earnings growth (last year) | +203.68% |
| Earnings growth (this year) | -- |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -23.01% |
| P/E ratio | -- |
| Price/Sales | 1.96 |
| Price/Book | 5.35 |
Competitors
Data as of 3:48pm ET, 05/31/2023
Financials
| Next reporting date | -- |
| EPS forecast (this quarter) | -- |
| Annual revenue (last year) | $36.1B |
| Annual profit (last year) | $18.4B |
| Net profit margin | 15.21% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Middlesex, Greater London |
Forecasts
Chart unavailable
